v3.22.2.2
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
 9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarized the changes in the contract asset and liability balances for the nine months ended September 30, 2022:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2022
$11,412 
Transferred to trade receivable of contract asset included in beginning of the year contract asset(11,412)
Contract asset, net of transferred to trade receivables on contracts during the period6,281 
Contract asset, September 30, 2022
$6,281 
Contract Liability
Contract liability, January 1, 2022
$11,946 
Recognition of revenue included in beginning of year contract liability$(6,054)
Contract liability, net of revenue recognized on contracts during the period8,534 
Foreign currency translation(120)
Contract liability, September 30, 2022
$14,306 
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three and nine months ended September 30, 2022 and 2021 (dollar amounts in thousands):
Three Months Ended September 30, 2022Three Months Ended September 30, 2021Nine Months Ended September 30, 2022Nine Months Ended September 30, 2021
Neurosurgery$193,848 $199,210 $588,818 $591,064 
Instruments55,948 57,287 166,149 163,511 
Total Codman Specialty Surgical249,796 256,497 754,967 754,575 
Wound Reconstruction and Care104,625 99,744 304,149 291,058 
Private Label30,770 30,620 100,528 91,291 
Total Tissue Technologies (1)
135,395 130,364 404,677 382,349 
Total revenue$385,191 $386,861 $1,159,644 $1,136,924